HCPLive Network

Multiple Sclerosis

Over the past 7 years, multiple sclerosis (MS) care costs rose 60% and were driven by common MS sequelae, according to new research.
Regional damage in the brain could be the main contributing factor to fatigue, a symptom of multiple sclerosis.
Many patients with multiple sclerosis have numerous comorbid chronic conditions that worsen mental health and increase mortality.
Although tumor necrosis factor inhibitors have dramatically improved management strategies for autoimmune disorders such as rheumatoid arthritis and inflammatory bowel disease, the biologic agents also pose a number of significant side effects that physicians must consider.
Human embryonic stem cells are a potentially viable treatment option for multiple sclerosis.
MRI technology can allow scientists to assess the development of depression and treatment responses over time in multiple sclerosis patients.
Multiple Sclerosis Resources
$AD300x250BB$